Precision medicine is available for your patients today. Pharmacogenetics is the science that combines genetics with pharmacology. Your genes dictate how you react to a certain medicine. This is individual for all of us, and this science can be used to personalize the medication for patients as individuals. Pharmacogenetics is disrupting medication as the cost of genetic testing has dropped from thousands of euros to hundreds of euros. Scientific evidence shows that pharmacogenetics gives better clinical outcomes for the patient and better cost efficiency for society. Particularly in treatment of depression and geriatric polypharmacy. Evidence is strong also in the treatment of coronary heart disease, and stroke. We at Abomics make pharmacogenetics an easy tool for doctors in their daily clinical work. Based on a simple blood test, we provide doctors with a patient specific report that shows whether a specific medicine is suitable for a patient or not and how the dosage should be adjusted. Abomics PGx – Pharmacogenetic interpretation service for personalized precision medication. Abomics GeneRx – Pharmacogenetic clinical decision support database. Our core end customers are: - Psychiatrists (depression) - Geriatricians (polypharmacy) - Cardiologists (coronary heart disease) - Neurologists (stroke). Our direct customers are: - Clinical laboratories - SW providers: o EHR / electronic prescribing systems o Medical Database and DSS providers
| Website | https://abomicspgx.com/ |
| Revenue | $5 million |
| Employees | 18 (0 on RocketReach) |
| Founded | 2013 |
| Address | 4 b Tykistökatu, Turku, Southwest Finland 20520, FI |
| Phone | +358 2 4542500 |
| Technologies | |
| Industry | Hospitals and Health Care, Business Services General, Medical, Genetic testing, Business Services, Health Care, Pharmacogenetics, Genomic information, Decision Support Systems |
| Keywords | Pharmacogenomics, Precision Medicine, Drug Response, Gene Testing, Genetic Testing, Personalized Medicine, Pharmacology, Genetics, Genomics, Dna Testing, Healthcare, Biotechnology, Clinical Diagnostics, Medical Testing, Pharmaceutical, Therapeutics, Biomarkers, Drug Development, Patient Care, Health Technology |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Abomics Oy employee's phone or email?
The Abomics Oy annual revenue was $5 million in 2026.
Abomics Oy is based in Turku, Southwest Finland.
The NAICS codes for Abomics Oy are [541, 54, 541713, 54171, 5417].
The SIC codes for Abomics Oy are [873, 87].